These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21214215)

  • 21. A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation.
    Charkoudian LK; Pham DM; Franz KJ
    J Am Chem Soc; 2006 Sep; 128(38):12424-5. PubMed ID: 16984186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2008 Jan; 51(2):331-44. PubMed ID: 18159922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.
    Horackova M; Ponka P; Byczko Z
    Cardiovasc Res; 2000 Aug; 47(3):529-36. PubMed ID: 10963725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
    Becker E; Richardson DR
    J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.
    Lukinova N; Iacovelli J; Dentchev T; Wolkow N; Hunter A; Amado D; Ying GS; Sparrow JR; Dunaief JL
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1440-7. PubMed ID: 19182262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chelation of lysosomal iron protects against ionizing radiation.
    Berndt C; Kurz T; Selenius M; Fernandes AP; Edgren MR; Brunk UT
    Biochem J; 2010 Dec; 432(2):295-301. PubMed ID: 20846118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities.
    Blat D; Weiner L; Youdim MB; Fridkin M
    J Med Chem; 2008 Jan; 51(1):126-34. PubMed ID: 18078312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
    Chen YL; Kong X; Xie Y; Hider RC
    J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
    Simůnek T; Sterba M; Popelová O; Kaiserová H; Adamcová M; Hroch M; Hasková P; Ponka P; Gersl V
    Br J Pharmacol; 2008 Sep; 155(1):138-48. PubMed ID: 18536744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Nov; 50(24):6212-25. PubMed ID: 17963372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.
    Di Stefano A; Sozio P; Cocco A; Iannitelli A; Santucci E; Costa M; Pecci L; Nasuti C; Cantalamessa F; Pinnen F
    J Med Chem; 2006 Feb; 49(4):1486-93. PubMed ID: 16480285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study.
    Kovaríková P; Klimes J; Sterba M; Popelová O; Gersl V; Ponka P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 838(2):107-12. PubMed ID: 16725389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity.
    Hašková P; Koubková L; Vávrová A; Macková E; Hrušková K; Kovaříková P; Vávrová K; Simůnek T
    Toxicology; 2011 Nov; 289(2-3):122-31. PubMed ID: 21864640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPLC study on stability of pyridoxal isonicotinoyl hydrazone.
    Kovaríková P; Mokrý M; Klimes J; Vávrová K
    J Pharm Biomed Anal; 2006 Jan; 40(1):105-12. PubMed ID: 16061341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotective Potential of Iron Chelators and Prochelators.
    Jansová H; Šimůnek T
    Curr Med Chem; 2019; 26(2):288-301. PubMed ID: 28933303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells.
    Lovejoy DB; Richardson DR
    Blood; 2002 Jul; 100(2):666-76. PubMed ID: 12091363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.
    Fibach E; Rachmilewitz EA
    Ann N Y Acad Sci; 2010 Aug; 1202():10-6. PubMed ID: 20712766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy.
    Bernhardt PV; Chin P; Richardson DR
    J Biol Inorg Chem; 2001 Oct; 6(8):801-9. PubMed ID: 11713687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N; Buss JL; Soe-Lin S; Felfly H; Trudel M; Ponka P
    Exp Hematol; 2008 Jul; 36(7):773-85. PubMed ID: 18456387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron-chelator complexes as iron sources for early developing human erythroid precursors.
    Leimberg JM; Prus E; Link G; Fibach E; Konijn AM
    Transl Res; 2008 Feb; 151(2):88-96. PubMed ID: 18201676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.